Sweat gland or hair follicle? - Eccrine spiradenoma.


Journal of Cancer Immunology and Therapy is peer-reviewed, open access, scholarly journal. It mainly aims at publishing the latest advancements in the field, enriching our understanding of Caner Immunology and Therapy such as a forum for new concepts and advances in basic Cancer Discovery, Cancer Epidemiology, Biomarkers & Prevention, Cancer Immunology Research, Cancer Surgery, Advances in Cancer Prevention, Breast Cancer, Cancer Biology, Cancer Treatment, Cancer Management and Research, Integrative Cancer Therapies, Clinical cancer immunology and therapy.

Eccrine spiradenoma was described in 1956 by Kersting and Helwig who designated eccrine spiradenoma as a benign dermal neoplasm derived from the eccrine sweat glands . An infrequent, exceptional neoplasm, eccrine spiradenoma principally cogitates as a solitary, intra-dermal, painful nodule. The neoplasm is considered to originate from the cutaneous sweat glands with a concomitant, focal apocrine differentiation. The disorder is occasionally exemplified by multiple tumours. Frequent sites delineated with eccrine spiradenoma are the chest and face. Infrequently, lumps can be delineated across the forearm, eyelids or the joints, particularly the elbow. The tender nodules display a gradual evolution with amplifying magnitude. Therapeutic strategy of managing tumours such as eccrine spiradenoma is not well delineated. Surgical excision remains the therapeutic option of choice with minimal incidence of reoccurrences.

We publish the article related to the effects of dual diagnosis, Treatment, outcomes of the treatment. We invite different types of science communications including original research article, systematic reviews, short note communications, case reports, Editorials, letters to the Editors and expert opinions & commentaries from different regions for publication.

Authors can submit their manuscripts as an email attachment to the following e-mail id cancerimmunol@eclinicalsci.com